Why A Wisconsin-Developed Ebola Vaccine Represents A Breakthrough

Clinical Trials Will Build On Decade Of Research Into Deadly Virus

6
han-health-science-ebola-vaccine-research-njai

Njai: « We may be able to develop much more efficient, much better novel therapies for Ebola. »

Researchers at the University of Wisconsin-Madison’s Waisman Center are working to develop an experimental vaccine for the deadly Ebola virus, and announced in February 2018 that they’ll begin phase 1 human clinical trials in Japan by the end of the year. The vaccine has already been tested successfully on monkeys, and the next step is to figure out how exactly those human clinical trials will work.

First identified after 1976 outbreaks in Sudan and Zaire (now the Democratic Republic of the Congo), Ebola virus disease has been particularly hard on people in central and western Africa. In most years, World Health Organization data shows, Ebola might strike a few dozen or a few hundred people. But between 2014 and 2016, a major outbreak struck Guinea, Liberia and Sierra Leone, infecting more than 28,000 people and killing more than 11,000 of those patients. Sporadic cases were found in several other West African nations, with additional isolated and secondary cases in Europe and the United States.

A UW-Madison School of Veterinary Medicine lab led by Dr. Yoshihiro Kawaoka, a virologist, is tackling the Ebola virus as a whole. Kawaoka has studied Ebola for decades, and is also known for his research on human and avian influenza viruses.

Dr. Alhaji Njai, one of the scientists working on the vaccine project in Kawaoka’s lab, is a postdoctoral researcher and a native of Sierra Leone. In a March 2, 2018 interview with Wisconsin Public Television’s Here & Now, he explained the scientific and public health ramifications of the new Ebola vaccine.

« [In 2014], we set up a functional lab system in Sierra Leone through Professor Yoshihiro Kawaoka’s group working on the vaccine, but also looking at some of the molecular causes — why does Ebola kill, why is Ebola so lethal and why do some people survive Ebola? » Njai said. « So, trying to understand more on sort of what are the host pathogen responses around it and then by so doing, we may be able to develop much more efficient, much better novel therapies for Ebola. » The Kawaoka lab isn’t the first to try to develop an Ebola vaccine.

Pharmaceutical giant Merck began clinical trials of a vaccine in Guinea in 2015, and reported successful results among thousands of people. However, as a 2017 article in MIT Technology Reviewexplains, this advance, significant as it is, only reveals so much. It’s not clear how long the Merck vaccine’s protection lasts, and it doesn’t cover all strains of the virus.

While progress is being made, the deadly nature of Ebola remains a problem that can benefit from multiple approaches, and the vaccine developed in Wisconsin has one crucial difference.

« So much of the vaccine candidates out there are like fragments of the virus, » he said. « What we have now is actually the whole Ebola virus minus… the gene responsible for Ebola to attach to human cells. So what we’ve done is just basically knock out that gene and then without that gene, the Ebola virus is unable to replicate and it’s also unable to attach to human cells. »

Despite Ebola’s horrific reputation — as a viral hemorrhagic fever, its symptoms include violent diarrhea, vomiting, and internal and external bleeding — patients can survive infection, and a lot of its toll has to do with failures of prevention policy and public health infrastructure.

Created in March 2015, the « Survivor Wall » at the Bong Ebola Treatment Unit in Libera displayed the handprints of patients who survived their infection by the Ebola virus.

Njai, who frequently travels to Sierra Leone and founded Project 1808, a non-profit aimed at supporting community and technical development in that nation, said the Wisconsin-developed vaccine holds great promise for the people most at risk of Ebola.

« Having a vaccine that works, and if we have it to work in phase one in December, that will be tremendous news for not just the medical world, but also for the people of Sierra Leone and West Africa because we know whenever Ebola hits, it has the likelihood of coming back, » he said.

 

SHARE
Previous articleInterim Injunction: NEC Commits Security Custody of Run-off Materials to Forces
Next articleDr. Samura: We’re Working with NGC!
Abu Bakarr Tarawally is a Journalist based in Freetown. He works for the Sierra Leone Broadcasting Corporation as a radio producer. He has once served as Editor for a few newspapers in Freetown, including Sierra Express Media, The Exclusive Newspaper and his own newspaper, the Daily Express Publications. He is a teacher trainer, and loves writing and reading a lot. Email: abstarawally@gmail.com. Call +232 88601277 or +2327661303.

6 COMMENTS

  1. I precisely wanted to thank you so much once more. I’m not certain what I might have taken care of in the absence of the entire aspects discussed by you concerning such area. It truly was a real fearsome circumstance in my opinion, however , viewing the specialised technique you resolved it made me to leap over fulfillment. Now i’m thankful for this support and thus pray you recognize what a great job you are always accomplishing educating the rest thru your site. More than likely you’ve never encountered any of us.

  2. I have to convey my affection for your kind-heartedness giving support to folks who actually need assistance with this particular topic. Your very own dedication to getting the solution all over was especially insightful and has frequently made men and women much like me to achieve their endeavors. The useful tutorial can mean a lot to me and substantially more to my peers. Thanks a ton; from all of us.

  3. I would like to show appreciation to the writer just for bailing me out of this type of issue. After exploring throughout the search engines and seeing techniques that were not powerful, I thought my entire life was gone. Existing without the presence of approaches to the issues you’ve solved all through the guideline is a critical case, and the ones that might have adversely damaged my entire career if I had not come across your web site. Your own talents and kindness in touching everything was precious. I’m not sure what I would’ve done if I hadn’t come across such a solution like this. I am able to at this point look forward to my future. Thank you very much for your specialized and result oriented guide. I won’t be reluctant to suggest the sites to any person who would need counselling about this situation.

  4. I would like to express some thanks to the writer just for rescuing me from such a scenario. After looking out through the search engines and meeting solutions which were not productive, I assumed my life was well over. Existing devoid of the approaches to the problems you’ve fixed by way of your good review is a crucial case, as well as the kind that could have adversely affected my entire career if I had not come across the blog. The knowledge and kindness in playing with all the pieces was excellent. I don’t know what I would have done if I hadn’t come upon such a solution like this. I can also at this moment look ahead to my future. Thanks very much for your high quality and amazing guide. I won’t think twice to suggest your blog post to anyone who needs to have care on this issue.

  5. I needed to compose you that bit of remark to help say thanks again for the pretty advice you’ve documented at this time. This has been simply extremely generous of people like you to grant unreservedly all that many of us could have marketed as an e book in making some money for themselves, specifically now that you might have tried it if you desired. These basics in addition worked to become a great way to understand that other people online have the identical dream like mine to grasp a little more with reference to this problem. I believe there are lots of more enjoyable opportunities in the future for folks who find out your blog post.

LEAVE A REPLY

Please enter your comment!
Please enter your name here